Status:
UNKNOWN
Profile Fecal Analysis of Neutropenic Enterocolitis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Neutropenic Enterocolitis
Eligibility:
All Genders
18+ years
Brief Summary
A prospective, single-center, cohort study to allow collecting observations of patients receiving induction chemotherapy for primary Acute Myeloid Leukemia (AML), collecting biological samples(includi...
Eligibility Criteria
Inclusion
- patient\>= 18 years old;
- cytological diagnosis of de novo Acute Myeloid Leukemia (AML) (\>20% myeloid blasts);
- eligible for intensive chemotherapy (no severe co-morbidity);
- not having received any prior chemotherapy;
- affiliation to the national social security system.
Exclusion
- acute promyelocytic leukemia (AML 3);
- inability to understand the nature of investigations or to give informed non-opposition;
- person subject to a legal protection measure.
Key Trial Info
Start Date :
July 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04438278
Start Date
July 8 2020
End Date
July 1 2023
Last Update
June 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AP-HP Hôpital Saint Louis
Paris, France